Help Us Accelerate Innovation!


BARDA Purchases New Anthrax Antitoxin

BARDA has purchased anthrax antitoxin from Elusys Therapeutics Inc., for the Strategic National Stockpile as part of an integrated, portfolio approach to protecting Americans from 21st century health security threats. This antitoxin can be used in conjunction with antibiotics to help protect Americans in the event of anthrax exposure. It was purchased using funding from Project BioShield, which funds the late-stage development and procurement of critical medical countermeasures.
Learn More

Help Us Accelerate Innovation!

BARDA has issued Requests for Information (RFIs) for transformative tools and technologies related to sepsis and for early detection and diagnosis of chemical and biological exposures and infections. If your organization is developing these capabilities, let us know by responding to these RFIs.
Learn More
Image of BARDA logos.
BARDA announces requests for information: Solving Sepsis and ENACT
Image of Hospital Preparedness Program logo
Hospital Preparedness Program:
15 Years of Health Care Preparedness and Response
Learn More
Coordination Between Hospital Coalition Partners
Learn More
Image of heatlh care professionals running to respond to an emergency
Response to a No-Notice Incident
Learn More
National Disaster Medical System:
Apply Today!
Learn More
Image of runners in Boston Marathon race
Responding to
Incidents Involving Explosives
Learn More

Leave your comment

Tu dirección de correo electrónico no será publicada.